dc.contributor.author | Atalar, E | |
dc.contributor.author | Haznedaroglu, I | |
dc.contributor.author | Aytemir, K | |
dc.contributor.author | Aksoyek, S | |
dc.contributor.author | Ovunc, K | |
dc.contributor.author | Oto, A | |
dc.contributor.author | Ozmen, F | |
dc.date.accessioned | 2019-12-10T11:21:48Z | |
dc.date.available | 2019-12-10T11:21:48Z | |
dc.date.issued | 2001 | |
dc.identifier.issn | 0160-9289 | |
dc.identifier.uri | https://doi.org/10.1002/clc.4960240211 | |
dc.identifier.uri | http://hdl.handle.net/11655/15514 | |
dc.description.abstract | Background: Adhesion molecules are known to be important in the regulation of endothelial cell and platelet functions. Increased platelets P-selectin expression is a marker of stent thrombosis after uncoated stent placement. Hypothesis: The aim of this study was to compare the effects of intracoronary placement of phosphorylcholine (PC)coated, versus heparin-coated, versus uncoated stents on platelets and endothelial activity. Methods: Thirty patients (age 55 +/- 10, 27 men) with significant proximal left anterior descending coronary artery stenoses were randomized to elective implantation of PC-coated, versus heparin-coated, versus uncoated stents. Following stent placement, intravenous heparin and aspirin plus ticlopidine were administered. Venous plasma soluble E-selectin. sP-selectin, and intercellular adhesion molecule-1 levels were measured before the procedure and 24 and 48 h thereafter as markers of platelet and endothelial cell activation. Patients were excluded if they had a disease known to influence platelet and endothelial cell function. Results: Plasma sP-selectin levels decreased significantly after implantation of PC- and heparin-coated stents (p = 0.04:), but remained unchanged in patients randomized to uncoated stents. Plasma sE-selectin levels increased significantly after uncoated stent placement (p = 0.01) and remained unchanged after coated stent implantation. Conclusion: In patients treated with combined antiplatelet therapy implantation of PC- and heparin-coated stents decreased platelet activity without activating endothelial cells, whereas placement of uncoated stents led to endothelial activation without changing platelet activity. These results suggest that PC-coated and heparin-coated stents may be advantageous in limiting thrombotic complications. | |
dc.language.iso | en | |
dc.publisher | Clinical Cardiology Publ Co | |
dc.relation.isversionof | 10.1002/clc.4960240211 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Cardiovascular System & Cardiology | |
dc.title | Effects Of Stent Coating On Platelets And Endothelial Cells After Intracoronary Stent Implantation | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Clinical Cardiology | |
dc.contributor.department | Kardiyoloji | |
dc.identifier.volume | 24 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 159 | |
dc.identifier.endpage | 164 | |
dc.description.index | WoS | |